MediPharm Labs (LABS) Competitors C$0.06 0.00 (0.00%) As of 11:51 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock LABS vs. TGOD, NINE, SUGR, WMD, MDP, VM, WLLW, HEXO, VIR, and ZOMShould you be buying MediPharm Labs stock or one of its competitors? The main competitors of MediPharm Labs include Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), SugarBud Craft Growers (SUGR), WeedMD (WMD), Medexus Pharmaceuticals (MDP), Voyageur Pharmaceuticals (VM), Willow Biosciences (WLLW), HEXO (HEXO), Viridium Pacific Group (VIR), and Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM). These companies are all part of the "drug manufacturers - specialty & generic" industry. MediPharm Labs vs. Its Competitors Green Organic Dutchman Delta 9 Cannabis SugarBud Craft Growers WeedMD Medexus Pharmaceuticals Voyageur Pharmaceuticals Willow Biosciences HEXO Viridium Pacific Group Zomedica Pharmaceuticals Corp. (ZOM.V) Green Organic Dutchman (TSE:TGOD) and MediPharm Labs (TSE:LABS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation. Which has higher valuation and earnings, TGOD or LABS? MediPharm Labs has higher revenue and earnings than Green Organic Dutchman. MediPharm Labs is trading at a lower price-to-earnings ratio than Green Organic Dutchman, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGreen Organic DutchmanC$31.37M0.00-C$137.58M-C$0.26N/AMediPharm LabsC$39.42M0.68-C$12.05M-C$0.03-2.24 Is TGOD or LABS more profitable? Green Organic Dutchman has a net margin of 0.00% compared to MediPharm Labs' net margin of -30.56%. Green Organic Dutchman's return on equity of 0.00% beat MediPharm Labs' return on equity.Company Net Margins Return on Equity Return on Assets Green Organic DutchmanN/A N/A N/A MediPharm Labs -30.56%-24.41%-7.17% Does the media favor TGOD or LABS? In the previous week, Green Organic Dutchman had 1 more articles in the media than MediPharm Labs. MarketBeat recorded 1 mentions for Green Organic Dutchman and 0 mentions for MediPharm Labs. Green Organic Dutchman's average media sentiment score of 0.00 equaled MediPharm Labs'average media sentiment score. Company Overall Sentiment Green Organic Dutchman Neutral MediPharm Labs Neutral Do institutionals and insiders have more ownership in TGOD or LABS? 0.7% of MediPharm Labs shares are owned by institutional investors. 4.5% of MediPharm Labs shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryGreen Organic Dutchman and MediPharm Labs tied by winning 5 of the 10 factors compared between the two stocks. Get MediPharm Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LABS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LABS vs. The Competition Export to ExcelMetricMediPharm LabsDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$26.98MC$2.20BC$5.52BC$6.20BDividend YieldN/A2.92%5.25%6.72%P/E Ratio-2.244.1527.7250.47Price / Sales0.68562.63367.061,211.67Price / Cash1.3010.3537.4283.29Price / Book0.5911.488.044.70Net Income-C$12.05MC$21.15BC$3.18BC$301.20M7 Day PerformanceN/A0.67%3.72%1.04%1 Month PerformanceN/A6.63%3.72%4.12%1 Year PerformanceN/A2.12%29.92%26.68% MediPharm Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LABSMediPharm LabsN/AC$0.07flatN/A-7.1%C$26.98MC$39.42M-2.24130TGODGreen Organic DutchmanN/AN/AN/AN/AC$89.95MC$31.37M-0.6541News CoverageGap UpHigh Trading VolumeNINEDelta 9 CannabisN/AC$1.03+3.0%N/A+0.0%C$89.36MC$12.87M19.07940Gap UpSUGRSugarBud Craft GrowersN/AC$13.00-3.0%N/A+57.6%C$88.66MC$575.64M15.6644WMDWeedMDN/AC$0.28-1.8%N/A+0.0%C$67.82MC$27.53M-0.66628Gap UpMDPMedexus PharmaceuticalsN/AC$3.01flatC$5.49+82.3%+33.0%C$67.39MC$100.25M14.3998VMVoyageur PharmaceuticalsN/AC$0.29+5.5%N/A+488.9%C$43.94MN/A-27.12N/AWLLWWillow BiosciencesN/AC$0.27+8.0%N/A+92.0%C$39.11MC$2.94M-4.9419Gap DownHEXOHEXON/AN/AN/AN/AC$38.72MC$124.10M-0.26690VIRViridium Pacific GroupN/AC$0.38+5.6%N/A+0.0%C$37.52MC$1.09M-2.97580Gap UpZOMZomedica Pharmaceuticals Corp. (ZOM.V)N/AC$0.29-6.6%N/A+0.0%C$36.73MN/A-2.6150Gap Down Related Companies and Tools Related Companies Green Organic Dutchman Competitors Delta 9 Cannabis Competitors SugarBud Craft Growers Competitors WeedMD Competitors Medexus Pharmaceuticals Competitors Voyageur Pharmaceuticals Competitors Willow Biosciences Competitors HEXO Competitors Viridium Pacific Group Competitors Zomedica Pharmaceuticals Corp. (ZOM.V) Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:LABS) was last updated on 7/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediPharm Labs Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediPharm Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LABS Stock Alerts